LFB 14-31 (L1)

General Information


DRACP ID  DRACP00053

Peptide Name   LFB 14-31 (L1)

Sequence  PEWFKCRRWQWRMKKLGA

Sequence Length  18

UniProt ID  P24627 

PubChem CID  Not available

Origin  Bovine Lactoferrin

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Meth A Mouse fibrosarcoma Sarcoma IC50>404 µM MTT assay 4 h 1
MT-1 Human mammary carcinoma Carcinoma IC50>404 µM MTT assay 4 h 1
HT-29 Colon adenocarcinoma Carcinoma IC50>404 µM MTT assay 4 h 1

Hemolytic Activity  Human red blood cells: EC50>404 µM

Normal (non-cancerous) Cytotoxicity  Fibroblas: IC50>404 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00053

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C112H168N34O22S2

Absent amino acids  DHINSTVY

Common amino acids  KRW

Mass  271030

Pl  11.65

Basic residues  6

Acidic residues  1

Hydrophobic residues  6

Net charge  5

Boman Index  -5249

Hydrophobicity  -133.89

Aliphatic Index  27.22

Half Life 
  Mammalian: 3.5 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  16500

Absorbance 280nm  970.59

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12366526

Title  Enhanced antitumor activity and selectivity of lactoferrin-derived peptides

Doi 10.1034/j.1399-3011.2002.21008.x

Year  2002

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.